Xencor (XNCR) Profit After Tax (2013 - 2026)
Xencor's (XNCR) quarterly Profit After Tax came in at -$130.5 million in Q1 2026, down 169.46% year-on-year from $187.8 million in Q1 2025, and down 1439.59% on a QoQ basis from -$8.5 million in Q4 2025.
Xencor (XNCR) Profit After Tax (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Profit After Tax data on file, last reported at -$130.5 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 169.46% year-over-year to -$130.5 million in Q1 2026; TTM through Mar 2026 was -$175.8 million, a 16.04% increase from a year earlier, with the FY2025 full-year figure at -$91.9 million, up 60.81% from the prior year.
- Profit After Tax for Q1 2026 stood at -$130.5 million, down from -$8.5 million in the prior quarter.
- Over the last five years, Profit After Tax for XNCR reached as high as $18.0 million in Q1 2022 and fell as low as -$130.5 million in Q1 2026.
- Historically, Profit After Tax has averaged -$38.1 million across 5 years, with a median of -$33.7 million in 2022.
- Across the five-year window, Profit After Tax surged 829.83% in 2022 and plunged 437.89% in 2023, its largest moves.
- Year by year, Profit After Tax stood at -$12.0 million in 2022, then tumbled by 50.03% to -$18.1 million in 2023, then sank by 147.64% to -$44.7 million in 2024, then jumped by 81.06% to -$8.5 million in 2025, then sank by 1439.59% to -$130.5 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$130.5 million in Q1 2026, -$8.5 million in Q4 2025, and -$6.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | -453.82 Mn |
| 10 | Xencor | 1.53 Bn | 1.14 Bn | - | -130.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130.47 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Sep 30, 2025 | -6.03 Mn |
| Jun 30, 2025 | -30.83 Mn |
| Mar 31, 2025 | -48.42 Mn |
| Dec 31, 2024 | -44.74 Mn |
| Sep 30, 2024 | -47.44 Mn |
| Jun 30, 2024 | -68.78 Mn |
| Mar 31, 2024 | -74.12 Mn |
| Dec 31, 2023 | -18.07 Mn |
| Sep 30, 2023 | -24.27 Mn |
| Jun 30, 2023 | -21.95 Mn |
| Mar 31, 2023 | -60.76 Mn |
| Dec 31, 2022 | -12.04 Mn |
| Sep 30, 2022 | -33.69 Mn |
| Jun 30, 2022 | -35.80 Mn |
| Mar 31, 2022 | 17.98 Mn |
| Dec 31, 2021 | 73.21 Mn |
| Sep 30, 2021 | -40.25 Mn |
| Jun 30, 2021 | 52.14 Mn |